Peptonic Medical Stock Current Ratio
| 28L Stock | 0.0002 0.00 0.00% |
PEPTONIC MEDICAL fundamentals help investors to digest information that contributes to PEPTONIC MEDICAL's financial success or failures. It also enables traders to predict the movement of PEPTONIC Stock. The fundamental analysis module provides a way to measure PEPTONIC MEDICAL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PEPTONIC MEDICAL stock.
PEPTONIC |
PEPTONIC MEDICAL Company Current Ratio Analysis
PEPTONIC MEDICAL's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, PEPTONIC MEDICAL has a Current Ratio of 0.0 times. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Drug Manufacturers-Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
PEPTONIC Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PEPTONIC MEDICAL's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PEPTONIC MEDICAL could also be used in its relative valuation, which is a method of valuing PEPTONIC MEDICAL by comparing valuation metrics of similar companies.PEPTONIC MEDICAL is currently under evaluation in current ratio category among its peers.
PEPTONIC Fundamentals
| Return On Equity | -1.14 | |||
| Return On Asset | -0.52 | |||
| Profit Margin | (1.88) % | |||
| Shares Outstanding | 396.79 M | |||
| Gross Profit | 19.07 M | |||
| Book Value Per Share | 0.72 X | |||
| Earnings Per Share | (0.19) X | |||
| Beta | 0.58 | |||
| Market Capitalization | 3.77 M |
About PEPTONIC MEDICAL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PEPTONIC MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PEPTONIC MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PEPTONIC MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in PEPTONIC Stock
PEPTONIC MEDICAL financial ratios help investors to determine whether PEPTONIC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PEPTONIC with respect to the benefits of owning PEPTONIC MEDICAL security.